The global healthcare landscape is witnessing critical structural transformations, placing infectious disease management at the center of clinical priorities. According to recent comprehensive industry tracking, the global Anti-Infective Drugs Market—which was valued at USD 135 billion in 2022 and climbed toward USD 184.7 billion by 2030—is maintaining an architectural shift in...